Theratechnologies Inc. (TSE:TH) shares traded up 1.1% during trading on Monday . The company traded as high as C$6.64 and last traded at C$6.43. 123,094 shares were traded during trading, a decline of 21% from the average session volume of 155,844 shares. The stock had previously closed at C$6.50.
A number of analysts have issued reports on TH shares. Scotiabank lowered their target price on Theratechnologies from C$10.00 to C$9.25 and set an “outperform” rating on the stock in a report on Friday, October 6th. National Bank Financial raised their target price on Theratechnologies from C$9.25 to C$9.75 and gave the company an “outperform” rating in a report on Thursday, October 5th.
Theratechnologies Inc is a specialty pharmaceutical company. The Company addresses medical needs to promote healthy living among human immunodeficiency virus (HIV) patients. Its products include EGRIFTA and Ibalizumab. EGRIFTA (tesamorelin for injection) refers to tesamorelin and it is indicated for the reduction of excess abdominal fat in HIV infected patients with lipodystrophy.
What are top analysts saying about Theratechnologies Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Theratechnologies Inc. and related companies.